These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 18481809

  • 1. Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies.
    Vermorken JB, Herbst RS, Leon X, Amellal N, Baselga J.
    Cancer; 2008 Jun 15; 112(12):2710-9. PubMed ID: 18481809
    [Abstract] [Full Text] [Related]

  • 2. Drug Insight: cetuximab in the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck.
    Bernier J.
    Nat Clin Pract Oncol; 2008 Dec 15; 5(12):705-13. PubMed ID: 18825142
    [Abstract] [Full Text] [Related]

  • 3. Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck.
    Baselga J, Trigo JM, Bourhis J, Tortochaux J, Cortés-Funes H, Hitt R, Gascón P, Amellal N, Harstrick A, Eckardt A.
    J Clin Oncol; 2005 Aug 20; 23(24):5568-77. PubMed ID: 16009950
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Greenhalgh J, Bagust A, Boland A, Fleeman N, McLeod C, Dundar Y, Proudlove C, Shaw R.
    Health Technol Assess; 2009 Oct 20; 13 Suppl 3():49-54. PubMed ID: 19846029
    [Abstract] [Full Text] [Related]

  • 8. Palliative weekly chemotherapy along with cetuximab in recurrent and metastatic head and neck cancers: a retrospective analysis.
    Rangaraju RR, Sharma JB, Dewan AK, Anand AK, Sheh R, Jena A, Chaturvedi AK.
    Indian J Cancer; 2012 Oct 20; 49(1):1-5. PubMed ID: 22842160
    [Abstract] [Full Text] [Related]

  • 9. Paclitaxel and cetuximab combination efficiency after the failure of a platinum-based chemotherapy in recurrent/metastatic head and neck squamous cell carcinoma.
    Péron J, Ceruse P, Lavergne E, Buiret G, Pham BN, Chabaud S, Favier B, Girodet D, Zrounba P, Ramade A, Fayette J.
    Anticancer Drugs; 2012 Oct 20; 23(9):996-1001. PubMed ID: 22643048
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phase II study of cetuximab in combination with docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck after platinum-containing therapy: a multicenter study of the Arbeitsgemeinschaft Internistische Onkologie.
    Knoedler M, Gauler TC, Gruenwald V, Matzdorff A, Schroeder M, Dietz A, Jordan WO, Arnold D, Hennemann B, Hofele C, Weissinger F, Eberhardt W, Keilholz U.
    Oncology; 2013 Oct 20; 84(5):284-9. PubMed ID: 23445718
    [Abstract] [Full Text] [Related]

  • 12. Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial.
    Rivera F, García-Castaño A, Vega N, Vega-Villegas ME, Gutiérrez-Sanz L.
    Expert Rev Anticancer Ther; 2009 Oct 20; 9(10):1421-8. PubMed ID: 19828002
    [Abstract] [Full Text] [Related]

  • 13. Cetuximab-Carboplatin-5-Fluorouracil Regimen in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma: A French Retrospective Survey.
    Burgy M, Barthélémy P, Lefevre F, Dupret-Bories A, Truntzer P, Korenbaum C, Flesch H, Bronner G, Borel C.
    Oncology; 2017 Oct 20; 93(1):11-17. PubMed ID: 28423384
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Paclitaxel is effective in relapsed head and neck squamous cell carcinoma: a retrospective study of 66 patients at a single institution.
    Fayette J, Montella A, Chabaud S, Bachelot T, Pommier P, Girodet D, Racadot S, Montbarbon X, Favier B, Zrounba P.
    Anticancer Drugs; 2010 Jun 20; 21(5):553-8. PubMed ID: 20220515
    [Abstract] [Full Text] [Related]

  • 16. Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 study.
    Urba S, van Herpen CM, Sahoo TP, Shin DM, Licitra L, Mezei K, Reuter C, Hitt R, Russo F, Chang SC, Hossain AM, Frimodt-Moller B, Koustenis A, Hong RL.
    Cancer; 2012 Oct 01; 118(19):4694-705. PubMed ID: 22434360
    [Abstract] [Full Text] [Related]

  • 17. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.
    Yokota T, Onozawa Y, Boku N, Hamauchi S, Tsushima T, Taniguchi H, Todaka A, Machida N, Yamazaki K, Fukutomi A, Yasui H.
    Jpn J Clin Oncol; 2011 Dec 01; 41(12):1351-7. PubMed ID: 21980053
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
    Kiyota N, Tahara M, Kadowaki S, Fuse N, Doi T, Minami H, Ohtsu A.
    Jpn J Clin Oncol; 2009 Apr 01; 39(4):225-30. PubMed ID: 19211574
    [Abstract] [Full Text] [Related]

  • 20. Cetuximab in the treatment of head and neck cancer.
    Bernier J.
    Expert Rev Anticancer Ther; 2006 Nov 01; 6(11):1539-52. PubMed ID: 17134359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.